STAT — Reporting from the frontiers of health and medicine
- Biotech Acadia drug meets endpoints for treating Rett syndrome, a rare neurological disease
- Health Patients and doctors are clashing about side effects of hormonal birth control
- First Opinion Covid-19 is fueling a pandemic of violence against women and girls
- First Opinion Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing
- First Opinion It’s time to open up health care’s secret analytics
- Biotech Acadia drug meets endpoints for treating Rett syndrome, a rare neurological disease
- Health Patients and doctors are clashing about side effects of hormonal birth control
- First Opinion Covid-19 is fueling a pandemic of violence against women and girls
- First Opinion Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing
- First Opinion It’s time to open up health care’s secret analytics
Exclusive analysis of biotech, pharma, and the life sciences
- Health Patients and doctors are clashing about side effects of hormonal birth control
- Health Early data from South Africa hints Omicron variant may cause less severe Covid, but more research is needed
- Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
-
- First Opinion The Fifth Circuit Court got the science wrong on OSHA’s vaccination mandate
- Special Report How an inconspicuous slaughterhouse keeps the world’s premature babies alive
- First Opinion How a ‘fatally, tragically flawed’ paradigm has derailed the science of obesity
- Biotech Acadia drug meets endpoints for treating Rett syndrome, a rare neurological disease
- Health A reason for optimism on Omicron: Our immune systems are not blank slates
